维普中文期刊产品整合服务
54篇 您的检索式:作者名="Ghetie"
    题名 作者 年代 出处 被引量
1在周期性的 glucagonoma 的骨头损害: 一份案例报告和文学的评论显示文摘 Glucagonomas are rare neuroendocrine tumors that arise from cells of the pancreatic islets. Most of them are malignant and usually present as metastatic disease. Sites most commonly involved in metastases are the liver and regional lymph nodes. Bone metastases are rare events and only a few cases have been reported in the literature. We present the case of a 53-year-old male with a medical history of recurrent non-functioning glucagonoma. He presented 17 years after the initial diagnosis with new blastic bone lesions involving the T1 vertebra and the sacrum. Diagnostic steps and medical management in metastatic glucagonoma are also reviewed.Cristian Ghetie Daniel Cornfeld Vassilios S Ramfidis Kostas N Syrigos Muhammad W Saif 2012World Journal of Gastrointestinal Oncology2012,4,6:2
2Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug- resistant B-cell lymphoma cell lines显示文摘Pop IV Pop LM Ghetie MA 2009Leuk Lyrnphoma2009,509,7:1
3The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti- CD19 antibody or an anti-CD19 immunotoxin 显示文摘Ghetie MA Tucker K Richardson J 1992Blood1992,80,9:1
4Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin显示文摘Ghetie MA Bright H Vitetta ES 2001Blood2001,97,5:1
5Disseminated or localized growth of a human B-cell tumor (Dandi) in SCID mice 显示文摘Ghetie MA Richardson J Tucker T 1990Int J Cancer1990,45,3:1
6Treatmcnt of SCID/human B cell precursor ALL with anti CD19 and anti-CD22 immunotoxins 显示文摘HERRERA L YARBROUGH S GHETIE V 2003Leukemia2003,17,33:1
7Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo显示文摘Spiridon CI Ghetie MA Uhr J 2002Clin Cancer Res2002,8,6:1
8Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins显示文摘Hen'era L Yarbrough S Ghetie V 2003Leukemia2003,17,2:1
9Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo显示文摘Spiridon CI Ghetie MA Uhr J 2002Clin Cancer Res2002,8,6:1
10Localization of the site of murine IgG1 molecule that is involvec in binding to the murine intestinal Fc receptor显示文摘KIM J K TSEN M F GHETIE V 1994Eur J Immunol1994,24,:1
11FcRn:the MHC class I-related receptor that is more than an IgG transporter显示文摘Ghetie V Ward ES 1997Immunol Today1997,18,12:1
12Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells显示文摘Ghetie MA Ghetie V Vitetta ES 1999Clin Cancer Res1999,5,:1
13Receptor for polymerized albumin on liver cells显示文摘Lenkei R Onica D Ghetie V 1977Experientia1977,30,8:1
14Homodimerization of Tumor - reactive Monoelonal Antibodies Markedly Increases Their Ability to Induce Growth Arrest or Apoptosis of Tumor Ceils显示文摘Ghetie M A Podar E M Ilgen A 1997The National Academy of Sciences of the USA1997,94,:1
15Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in muhidrug-resistant B-cell lymphoma cell lines 显示文摘Pop I V Pop L M Ghetie M A 2009Leuk Lymphoma2009,50,7:1
16Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemothera peutic agent and an immunotoxin显示文摘Ghetie MA Bright H Vitetta ES 2001Blood2001,97,:1
17Increasing the serum persistence of an IgG fragment by random mutagenesis显示文摘Ghetie V Popov S Borvak J 1997Nat Biotechnol1997,15,7:1
18Homo- dimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells显示文摘Ghetie M A Podar E M Ilgen A 1997The National Academy of Sciences of the USA1997,94,:1
19Homodimers but not monomers of Rituxan(chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin显示文摘Ghetie M A Bright H Vitetta E S 2001Blood2001,97,:1
20Multiple roles for the major histocompatibility complex class I -related receptor FcRn显示文摘GHETIE V WARD E S 2000Annu Rev Immunol2000,18,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费